SRSF3P2

Across TCGA pan-cancer cohorts, SRSF3P2 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SRSF3P2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher SRSF3P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SRSF3P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and MESO show a favorable association.

UCS, UCEC, and THCA are the cancer types where SRSF3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.096	0.699	<.001	72	view →
UCEC	DFS	Tertile	All	0.739	0.848	.017	48	view →
THCA	DFS	Tertile	II,III,IV	0.601	0.894	.022	18	view →
OV	DFS	Tertile	IV	0.354	0.511	.041	12	view →
PRAD	OS	Tertile	All	0.968	0.996	.014	12	view →
SKCM	OS	Tertile	All	0.962	0.865	.029	9	view →
PCPG	OS	Tertile	All	0.841	0.974	.048	9	view →
SARC	OS	Tertile	All	0.548	0.784	.021	9	view →
MESO	OS	Tertile	II,III,IV	0.482	0.232	.023	6	view →
BRCA	OS	Tertile	II,III,IV	0.338	0.599	.039	6	view →
KIRC	DFS	Tertile	III,IV	0.827	0.702	.042	4	view →
KIRP	OS	Tertile	All	0.477	0.725	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SRSF3P2–UCS (OS)

Open the UCS breakdown →